What Causes Human Papilloma Cancer HPV

Life-or-death questions are being raised about Gardasil, an acidic vaccine touted to prevent a so-called infection of human papilloma virus (HPV), which can theoretically may cause cervical cancer. Merck & Co., Inc., the maker of Gardasil, staunchly defends its multi-billion dollar goldmine, stating on their website, “We are confident in the safety profile of GARDASIL.”

But Dr. Diane Harper, an obstetrician and gynecologist who helped Merck perform Gardasil’s clinical trials and who served on Merck’s advisory board for the vaccine, told CNN in an interview, “Gardasil is not without risks. It’s not a freebie.”

Since the approval of the vaccine by the FDA in 2006, health-care groups have shouted out warnings of danger, and have also said that Merck has energetically mass-marketed Gardasil with disregard both for known current side effects as well as for possible long-term side effects.

Here are some of the established acidic risks, according to the Centers for Disease Control and Prevention (CDC):

Death. According to the CDC, more than 25 million doses of Gardasil have been distributed in the United States as of June 1, 2009, resulting in 43 deaths. Gardasil is the confirmed cause in 26 of those deaths, 9 are still being investigated, and 8 remain unconfirmed.

Guillain-Barré Syndrome (GBS). Cases of GBS, a peripheral neuropathy that can result in paralysis and death, have been reported to the CDC as a result of Gardasil vaccination.

Blood Clots. Clots occurring in the heart, lungs and legs have reportedly been triggered by this toxic acidic Gardasil.

About 40 percent of adverse effects occur on the day of vaccination. Approximately 14,000 reports have been made, with 93 percent considered by the CDC to be “non-serious,” and 7 percent to be “serious.”

What does the reporting of 14,000 incidents of side effects really mean? In an interview with Dr. Russell Blaylock, a nationally recognized neurosurgeon, health practitioner, and editor of The Blaylock Wellness Report, said, “Multiply the number of incidents actually reported by ten and you’ll get an accurate number.”

As to the effectiveness of Gardasil in the first place, Dr. Blaylock said, “The vaccine has never been proven to be effective, and by the time the vaccine would be needed to prevent cancer would be years later and the vaccine would be long gone from the system. If you have the organism already in your cervix, the vaccine actually increases the cervical cancer rate.”

In the light of such serious side effects, the cost/benefit ratio in terms of both lives and money must be weighed. And some frightening facts are emerging about Gardasil. In an ABC interview, Dr. Harper said, “Although the number of serious adverse events is small and rare, they are real and cannot be overlooked or dismissed without disclosing the possibility to all other possible vaccine recipients.” Dr. Harper then dropped what some consider to be a bombshell: “The rate of serious adverse events is greater than the incidence rate of cervical cancer.”

In other words the drug Gardasil causes the very thing it is trying to prevent. Why? Because it is just another toxic acidic drug from the pharmaceutical companies who cares more about profits then about human life.

The U.S. Food & Drug Administration is currently pondering whether to approve the use of Gardasil on boys in order to protect their partners from cervical cancer. Last week, the FDA granted approval to allow GlaxoSmithKline’s new HPV vaccine called Cervarix to be sold in the United States.

HPV Vaccine Fact: “First, there are more than 100 different types of HPV and at least 15 of them are oncogenic [tending to cause tumors]. The current vaccines target only 2 oncogenic strains: HPV-16 and HPV-18. Second, the relationship between infection at a young age and development of cancer 20 to 40 years later is not known.”–Dr. Charlotte Haug in an editorial appearing in the August 19, 2009 Journal of the American Medical Association.

"Bottom line ALL so-called dis-ease and disease is caused by an over-acidification of the blood and tissues due to an inverted way of living, eating and thinking," states Dr. Robert O. Young, Director of the pH Miracle Living Center.

Read More

Another Fatty Liver Reversal, Part II

A month ago, I wrote about a reader "Steve" who reversed his fatty liver using a change in diet. Non-alcoholic fatty liver disease (NAFLD) is a truly disturbing modern epidemic, rare a few decades ago and now affecting roughly a quarter of the adult population of modern industrialized nations. Researchers cause NAFLD readily in rodents by feeding them industrial vegetable oils or large amounts of sugar.

Steve recently e-mailed me to update me on his condition. He also passed along his liver test results, which I've graphed below. ALT is a liver enzyme that enters the bloodstream following liver damage such as hepatitis or NAFLD. It's below 50 units/L in a healthy person*. AST is another liver enzyme that's below 35 units/L in a healthy person*.

Steve began his new diet in November of 2008 and saw a remarkable and sustained improvement in his ALT and AST levels:

Here's how Steve described his diet change to me:

I totally eliminated sugar, heavy starches, and grains. Started eating more whole, real foods, including things like grass-fed beef and pastured pork and eggs, began supplementing with good fats and omega-3 (pastured butter, coconut oil, cod liver oil). Ate more fruits and vegetables instead of refined carbs. Also completely gave up on the idea that I had to eat only "lean" meats. After my last results, the GI doc said that I wouldn't need the biopsy at all, that things were great, and that if I kept it up I "would live forever."

He did experience some side effects from this diet though:

My triglycerides also went from pre-diet measures of 201 and 147 to post diet 86, 81, and 71.

The added bonus, of course, was that my weight went from 205 pounds to 162 pounds and my body fat percentage from 24% to 12% in the matter of five months--all without the typically excessive cardio I used to try unsuccessfully for weight loss.

The liver is the body's "metabolic grand central station". It's essential for nutrient homeostasis, insulin sensitivity, detoxification, and hormone conversion, among other things. What's bad for the liver is bad for the rest of the body as well. Don't poison your liver with sugar and industrial vegetable oils.


* The cutoff depends on who you ask, but these numbers are commonly used.

How to Fatten Your Liver
Excess Omega-6 Fat Damages Infants' Livers
Health is Multi-Factorial
Fatty Liver Reversal
Another Fatty Liver Reversal

Read More

TOP THREE NATURAL HEALERS.

I did some research into herbal healing and found the top three natural healers can all be grown in your garden. They are used in alternative health as healers for a number of conditions.

1. Chamomile. The flowers from chamomile can be used in a tea and are calming and soothing and especially beneficial to the nerves and digestion. It is also very good for skin irritaions.

2. Rosemary. Rosemary helps memory and concentration, improves mood and sweetens breath.

3. Lavender. This herb can calm and relax, eases pain, and is an antiseptic for cuts and bruises.

I have grown all three herbs in my garden and use them on myself and family for all the above medicinal reasons.

Read More

The Pleomorphic Nature of Morgellons Syndrome

We report a possible basis of differentiation, based on the biophysical properties of fibers isolated from a Morgellons patient, as well as a future avenue of study for isolating the cause of Morgellons.

II. Discussion

A: Fiber Analysis

Fibers, upon inspection, were found to be fluorescent. The pictures (Figure 1A, 1B) show both a fiber and a hair sample from the same patient observed under white light and a Hofstead filter (with 365 excitiation). The fibers were visualized in scintillation vials with a Innotech detector, showing fluorescence with both a Hofstead filter (460 nm)and a green fluorescent filter (SYBR Green, 557 nm) upon excitation at both 305 and 365 nm. The fluorescence ceased after the illumination was extinquished. A single fiber is shown in Figure 1C.

The fiber shown in 1C was examined via SEM Microscopy at the University of Northern Arizona, with no additional modifications or treatments. SEM analysis demonstrated that the fiber appeared to be a normal hair follicle with scales (Figure 2A) and a typical root terminus (Figure 2B). The absence of a smooth surface denotes that the fiber does not seem to be coated with a protein monolayer.

In order to quantify the nature of the fluorescence, a cluster of fibers placed in nanopure deionized water were observed via a Hitachi Fluorometer. When observing the fibers, a characteristic fluorescent pattern emerged. This fluorescence pattern would account for fluorescence seen in the published pictures at the Morgellons research foundation web site. A fluorescent factor (protein) was isolated as described below, and found to have a similar pattern of fluorescence. The cuvette alone did not fluoresce, but an equivalent protein concentration of BSA (bovine serum albumin) gave a fluorescence which differed distinctly from the fiber fluorescence (potentially eliminating bovine albumin as a protein identity). Figure 3 shows the fluorescence observed.

Figure 1A: Fiber (top) and hair (bottom) viewed with white light

Figure 1B: Fiber top) and hair (bottom ) viewed with Hofstead filter (360 excitation with transilluminator)

Figure 1C: Single Fiber viewed with Hofstead filter and 360 excitation

Figure 2A: SEM of fiber body

Figure 2B: SEM of fiber root

Figure 3: (click here for the Fluorescence part of the report)

B. Fiber protein composition

Fibers from a patient with Morgellons Syndrome resisted dissolution in 6 M guandidine HCL, 6 M urea, and Trizol (Sigma) reagent. Fibers were ground in a mortar and pestle and resuspended in 2X SDS Buffer, and run on a 4-20% Tris Glycine Gel. Gel was coomassie stained and destained as described in Mantiatis (1998). 30 kDa, 60 kDa, protein bands were observed. (Figure 4, Lane 5). The predominant band was identified (from gel excision and in gel digest/nanoHPLC/MS at the University of Arizona Proteonomics Laboratory) as human serum albumin and cytoskeletal keratin II (67 kDa) with significant peptide fragment coverage over both protein sequences.

The fluorescent factor was isolated as a soluble component, and demonstrated to be a molecule of molecular weight greater than 10 kDa (through both dialysis and ultrafiltrations in Amicon Ultra 15 devices). (Isolation was simple: The gel running buffer in which the above protein samples were run in were found to be fluorescent. Incidently, the addition of GHCl to the SDS samples served to precipitate protein into a fibrillar format Buffer was filtered and purified via a C18 column (Waters C18 Sep-Pak)

Both a UV-Vis spectra of the buffer containing the fluorescent factor and a positive Bradford assay result confirmed that the fluorescent factor contained a protein component. Gel analysis of the fluorescent factor protein component demonstrated a protein with a molecular weight of 30 kDa, also found in the analysis of the entire fiber.

Interestingly enough, a similar nano-HPLC/MS analysis of this 30 kDa protein produced no human protein peak comparisons, and only single peptide fragments potentially corresponding to the following proteins (with approximate molecular weights corresponding to 30-40 kDa) were identified (Table 1). It may be noteworthy that the U/Az facility could not purify the protein using conventional methods from the buffer. Reportedly, a black tar-like oil precipitated under their assay conditions. This may denote other molecules that were potentially present in the buffer, originating from the fiber protein mixture.

Table 1: Peptide Fragment Listing for 30 kDa fluorescence associated protein

gi|225632m(casein alpha S1) bovine origin

gi|56477959m(probable iron-sulfur 4Fe-4S ferredoxin protein [Azoarcus sp. EbN1]_gi|56314002|emb|CAI08647.1| probable iron-sulfur 4Fe-4S ferredoxin protein [Azoarcus sp. EbN1])

gi|55420470probable alkene monooxygenase reductase [Nocardioides sp. JS614]

gi|34102607conserved hypothetical protein [Chromobacterium violaceum ATCC 12472]_gi|34496752|ref|NP_900967.1| hypothetical protein CV1297 [Chromobacterium violaceum ATCC 12472]

gi|68351715hypothetical protein TP02_0195 [Theileria parva]

gi|53689178COG0458: Carbamoylphosphate synthase large subunit (split gene in MJ) [Leuconostoc mesenteroides subsp. mesenteroides ATCC 8293]

___

III. Future direction:

The fluorescent factor protein was purified via C18 Sep-Pak chromatography, eluted with methanol/water (50:50) and rotary evaporated to dryness. The resultant powder should be sent to OSU Stillwater’s Proteonomic facility for MALDI-TOF and Edmund sequence analysis. MALDI-TOF will allow the identification of the exact mass of one (or several) proteins in the mixture, whereas Edmund sequence analysis will yield the first fifteen amino acids present in the protein sequence, allowing for either confirmation of the prior nano-HPLC/MS results or bioinformatics searches to obtain the protein identity. As of now, the samples have been sent to Dr. Wymore, due to complications with communicating with the Stillwater facility. Currently, this protein identity is unknown.

The fluorescence (associated with fibers), isolated to a protein composition, may be a unique feature to Morgellons patetients. The establishment of a diagnostic biochemical characteristic to Morgellons would greatly assist clinical practicioners in distinguishing between Morgellons and Delusional Parasitosis. Accordingly, it may be of significant interest to screen a wide variety of fibers from Morgellons patients for fluorescence, in order to establish this as a feature common to many patients. Similarly, it may be of interest to survey textile and cellulose fibers for fluorescence, in order to establish the fluorescent fiber hallmark as a unique, non-commerical, non-man-made entity. Further protein analysis of the fluorescent factor may yield clues to the infectious agent idenitity, as the protein does not, in this single sample, correspond to any potential human gene or protein product.

The techniques described here could also be applied to another physical manifestation of Morgellons: the emergence of black “specks” from the skin. A similar protein biochemical analysis of the specks may prove revealing in identifying the entity responsible for Morgellons.

Regardless, it must be emphasized that this is the sum result of a single patient with Morgellons, and thus not statistically accurate/valid as a potential portrayal of the Morgellons condition. Multiple analyses need to be conducted on multiple fibers from multiple patients, before this information should be scientifically reported.

Read More

Do you need help?

Do you need help with a health related problem?. Can I help with an alternative health remedy?. I am not a qualified person in relation to holistic cures but I do however have a wealth of information on this subject, and my aim is to help people who have any illness or disease

You can contact me here at Natural cures or at curesforyou on twitter

I look forward to hearing from you.

The very best of health to all of you.

Read More

Acupressure point to boost the immune system

Try this exercise every day, It strengthens the kidneys and the immune system, and boosts vitality.

The location of this acupressure point is on the lower back two finger widths on either side of the spine, approximately level with the waist. So that is in the centre of the back.

Fold your hands into the shape of a fist. Now bring your hands behind your back and using the knuckle of the hands use a rolling action around either side of the spine.

Try not to press too hard, do this for about one minute, once each day.

Read More

Chlorophyll, Chlorophyllin and Selenium in Reversing A Cancerous Condition

Research from the Linus Pauling Institute at Oregon State University suggests that natural compounds of chlorophyll, chlorophyllin, and selenium compounds, which previously have been studied for their ability to preventing a cancerous condition, may be able to play a more significant role in reversing a cancerous condition.

---

A new study just published in the International Journal of Cancer examined the activity of chlorophyllin and found that, on a dose-by-dose basis, it was 10 times more potent at causing death of colon cancer cells than hydroxyurea, a chemotherapeutic drug commonly used in cancer treatment.

Beyond that, chlorophyllin kills cancer cells by blocking the same phase of cellular division that hydroxyurea does, but by a different mechanism. This suggests that it – and possibly other “cocktails” of natural products – might be developed to have a synergistic effect with conventional cancer drugs, helping them to work better or require less toxic dosages, researchers said.

“We conclude that chlorophyllin has the potential to be effective in the clinical setting, when used alone or in combination with currently available cancer therapeutic agents,” the researchers wrote in their study.

The concept of combining conventional or new cancer drugs with natural compounds that have been shown to have anti-cancer properties is very promising, said Rod Dashwood, professor and director of the Cancer Chemoprotection Program in the Linus Pauling Institute.

“Most chemotherapeutic approaches to cancer try to target cancer cells specifically and do something that slows or stops their cell growth process,” Dashwood said. “We’re now identifying such mechanisms of action for natural compounds, including dietary agents. With further research we may be able to make the two approaches work together to enhance the effectiveness of cancer therapies.”

Chlorophyllin is a water-soluble derivative of chlorophyll – the green pigment found in most plants and many food products that makes possible the process of photosynthesis and plant growth from the sun’s energy. Chlorophyllin is inexpensive, and animal studies plus human clinical data suggest that it can be ingested at relatively high levels without toxicity.

In the new study, researchers found that pharmacologic doses of chlorophyllin caused colon cancer cells to spend more time than normal in their “synthesis phase” in which DNA is duplicated. Timing is critical to the various phases of cell growth, researchers said, and this disruption started a process that ultimately led to cell death, the study found.

In particular, the presence of high levels of chlorophyllin caused a major reduction in the level of ribonucleotide reductase, an enzyme critical to DNA synthesis, researchers found. This is also the mechanism of action of hydroxyurea, one drug already being used for cancer chemotherapy.

“In cancer research right now there’s interest in approaches that can reduce ribonucleotide reductase,” Dashwood said. “At the doses used in our experiments, chlorophyllin almost completely stops the activity of this enzyme.”

Further research is needed both in laboratory and animal studies, with combinations of chlorophyllin and existing cancer drugs, before it would be appropriate for human trials, Dashwood said. Chlorophyllin, in general, is poorly absorbed from the human gastrointestinal tract, so it’s unclear what levels might be needed for therapeutic purposes or how well they would work.

Other dietary agents also might have similar potential. Work just published by LPI researchers in the journals Carcinogenesis and Cancer Prevention Research explored the role of organic selenium compounds in killing human prostate and colon cancer cells. Colorectal and prostate cancers are consistently among the leading causes of cancer mortality in the United States, and will account respectively for 18 percent and 9 percent of all cancer deaths in 2009, according to estimates from the American Cancer Society.

In the recent studies, a form of organic selenium found naturally in garlic and Brazil nuts was converted in cancer cells to metabolites that acted as “HDAC inhibitors” – a promising field of research in which silenced tumor suppressor genes are re-activated, triggering cancer cell death.

“Whether it’s HDAC inhibition leading to one manner of cancer cell growth arrest, or loss of ribonucleotide reductase activity leading to another, as seen with chlorophyllin, there’s significant promise in the use of natural products for combined cancer therapies,” Dashwood said. “These are areas that merit continued research.”

These studies were supported by the National Cancer Institute and the National Institute of Environmental Health Sciences. Other collaborators included researchers from the New York Medical College and the Penn State College of Medicine.

Chlorophyll is identical to your hemoglobin except for the center atom. Dr. Robert O. Young's, at the pH Miracle Living Center in San Diego, California suggests, "as one increases their consumption of chlorophyll from green foods and green drinks the quality and quantity of the red blood cells improve. This can be noted on a CBC medical test as the red blood cell count increases and the hemoglobin increases to a healthy range. Liquid chlorophyll and chlorophyllin can be added to any water or green drink to improve the concentration of this powerful blood building compound."

http://www.phmiracleliving.com/p-306-liquid-chloropheal-4-oz.aspx

References: Chlorophyll and Chlorophyllin

1. Matthews CK, van Holde KE. Biochemistry. 2nd ed. Menlo Park: The Benjamin/Cummings Publishing Company; 1996.

2. Sudakin DL. Dietary aflatoxin exposure and chemoprevention of cancer: a clinical review. J Toxicol Clin Toxicol. 2003;41(2):195-204. (PubMed)

3. Dashwood RH. The importance of using pure chemicals in (anti) mutagenicity studies: chlorophyllin as a case in point. Mutat Res. 1997;381(2):283-286. (PubMed)

4. Egner PA, Stansbury KH, Snyder EP, Rogers ME, Hintz PA, Kensler TW. Identification and characterization of chlorin e(4) ethyl ester in sera of individuals participating in the chlorophyllin chemoprevention trial. Chem Res Toxicol. 2000;13(9):900-906. (PubMed)

5. Tachino N, Guo D, Dashwood WM, Yamane S, Larsen R, Dashwood R. Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen. Mutat Res. 1994;308(2):191-203. (PubMed)

6. Dashwood R, Yamane S, Larsen R. Study of the forces of stabilizing complexes between chlorophylls and heterocyclic amine mutagens. Environ Mol Mutagen. 1996;27(3):211-218. (PubMed)

7. Breinholt V, Schimerlik M, Dashwood R, Bailey G. Mechanisms of chlorophyllin anticarcinogenesis against aflatoxin B1: complex formation with the carcinogen. Chem Res Toxicol. 1995;8(4):506-514. (PubMed)

8. Egner PA, Munoz A, Kensler TW. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res. 2003;523-524:209-216. (PubMed)

9. Kumar SS, Devasagayam TP, Bhushan B, Verma NC. Scavenging of reactive oxygen species by chlorophyllin: an ESR study. Free Radic Res. 2001;35(5):563-574. (PubMed)

10. Kamat JP, Boloor KK, Devasagayam TP. Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim Biophys Acta. 2000;1487(2-3):113-127. (PubMed)

11. Park KK, Park JH, Jung YJ, Chung WY. Inhibitory effects of chlorophyllin, hemin and tetrakis(4-benzoic acid)porphyrin on oxidative DNA damage and mouse skin inflammation induced by 12-O-tetradecanoylphorbol-13-acetate as a possible anti-tumor promoting mechanism. Mutat Res. 2003;542(1-2):89-97. (PubMed)

12. Kumar SS, Shankar B, Sainis KB. Effect of chlorophyllin against oxidative stress in splenic lymphocytes in vitro and in vivo. Biochim Biophys Acta. 2004;1672(2):100-111. (PubMed)

13. Yun CH, Jeong HG, Jhoun JW, Guengerich FP. Non-specific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes. Carcinogenesis. 1995;16(6):1437-1440. (PubMed)

14. Dingley KH, Ubick EA, Chiarappa-Zucca ML, et al. Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutr Cancer. 2003;46(2):212-221. (PubMed)

15. Chimploy K, Diaz GD, Li Q, et al. Int J Cancer. 2009; in press.

16. Dashwood RH, Breinholt V, Bailey GS. Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay. Carcinogenesis. 1991;12(5):939-942. (PubMed)

17. Kensler TW, Groopman JD, Roebuck BD. Use of aflatoxin adducts as intermediate endpoints to assess the efficacy of chemopreventive interventions in animals and man. Mutat Res. 1998;402(1-2):165-172. (PubMed)

18. Simonich MT, Egner PA, Roebuck BD, et al. Natural chlorophyll inhibits aflatoxin B1-induced multi-organ carcinogenesis in the rat. Carcinogenesis. 2007;28(6):1294-1302. (PubMed)

19. Breinholt V, Hendricks J, Pereira C, Arbogast D, Bailey G. Dietary chlorophyllin is a potent inhibitor of aflatoxin B1 hepatocarcinogenesis in rainbow trout. Cancer Res. 1995;55(1):57-62. (PubMed)

20. Orner GA, Roebuck BD, Dashwood RH, Bailey GS. Post-initiation chlorophyllin exposure does not modulate aflatoxin-induced foci in the liver and colon of rats. J Carcinog. 2006;5:6. (PubMed)

21. Qian GS, Ross RK, Yu MC, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev. 1994;3(1):3-10. (PubMed)

22. Egner PA, Wang JB, Zhu YR, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A. 2001;98(25):14601-14606. (PubMed)

23. Chernomorsky SA, Segelman AB. Biological activities of chlorophyll derivatives. N J Med. 1988;85(8):669-673. (PubMed)

24. Siegel LH. The control of ileostomy and colostomy odors. Gastroenterology. 1960;38:634-636. (PubMed)

25. Weingarten M, Payson B. Deodorization of colostomies with chlorophyll. Rev Gastroenterol. 1951;18(8):602-604.

26. Christiansen SB, Byel SR, Stromsted H, Stenderup JK, Eickhoff JH. [Can chlorophyll reduce fecal odor in colostomy patients?]. Ugeskr Laeger. 1989;151(27):1753-1754. (PubMed)

27. Young RW, Beregi JS, Jr. Use of chlorophyllin in the care of geriatric patients. J Am Geriatr Soc. 1980;28(1):46-47. (PubMed)

28. Yamazaki H, Fujieda M, Togashi M, et al. Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients. Life Sci. 2004;74(22):2739-2747. (PubMed)

29. Kephart JC. Chlorophyll derivatives - their chemistry, commercial preparation and uses. Econ Bot. 1955;9:3-38.

30. Bowers WF. Chlorophyll in wound healing and suppurative disease. Am J Surg. 1947;73:37-50.

31. Carpenter EB. Clinical experiences with chlorophyll preparations. Am J Surg. 1949;77:167-171.

32. 2004 Physicians' Desk Reference. 58th ed. Stamford: Thomson Health Care, Inc.; 2003.

33. Smith RG. Enzymatic debriding agents: an evaluation of the medical literature. Ostomy Wound Manage. 2008;54(8):16-34. (PubMed)

34. Weir D, Farley KL. Relative delivery efficiency and convenience of spray and ointment formulations of papain/urea/chlorophyllin enzymatic wound therapies. J Wound Ostomy Continence Nurs. 2006;33(5):482-490. (PubMed)

35. Bohn T, Walczyk S, Leisibach S, Hurrell RF. Chlorophyll-bound magnesium in commonly consumed vegetables and fruits: relevance to magnesium nutrition. J Food Sci. 2004;69(9):S347-S350.

36. GPO Access. Electronic Code of Federal Regulations: Miscellaneous Internal Drug Products for Over the Counter Use. [Web page]. Available at: http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=
6bb427d78a48e3983e0456d15a058c40&rgn=div6&view=text&node=
21:5.0.1.1.27.5&idno=21. Accessed June 4, 2009.

37. GPO Access. Electronic Code of Federal Regulations: Listing of Color Additives Exempt from Certification [Web page]. Available at: http://ecfr.gpoaccess.gov/cgi/t/text/text-idx?c=ecfr&sid=
090fc8b3dcd5f08075f3d2d0c2654073&rgn=div8&view=text&node=
21:1.0.1.1.26.3.31.7&idno=21. Accessed June 4, 2009.

38. Hendler SS, Rorvik DR, eds. PDR for Nutritional Supplements. 2nd ed. Montvale: Physicians' Desk Reference, Inc; 2008.

39. Smith LW. The present status of topical chlorophyll therapy. N Y State J Med. 1955;55(14):2041-2050. (PubMed)

40. Gogel HK, Tandberg D, Strickland RG. Substances that interfere with guaiac card tests: implications for gastric aspirate testing. Am J Emerg Med. 1989;7(5):474-480. (PubMed)

---

Read More